-
Chagas Cardiomyopathy and Myocardial Sympathetic Denervation Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-24 Leonardo Pippa Gadioli, André Schmidt, Benedito Carlos Maciel, Gustavo Jardim Volpe, Marcus Vinicius Simões, José Antonio Marin-Neto
-
Evidence-Based Update on Transcatheter Therapies for Pulmonary Embolism Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-24 Peter Monteleone, Akash Patel, Jonathan Paul
-
Evolving Applications of Echocardiography in the Evaluation of Left Atrial and Right Ventricular Strain Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-22 Adam Serafin, Wojciech Kosmala, Thomas H. Marwick
-
Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-20 Roshan Bista, Mohamed Zghouzi, Manasa Jasti, Hady Lichaa, Jimmy Kerrigan, Elias Haddad, M. Chadi Alraies, Timir K. Paul
Purpose of Review This article presents a comprehensive review of coronary revascularization versus optimal medical therapy (OMT) in patients with severe ischemic left ventricular dysfunction. Recent Findings The REVIVED-BCIS2 trial randomized 700 patients with extensive coronary artery disease and left ventricular (LV) ejection fraction (LVEF) ≤ 35% and viability in more than four dysfunctional myocardial
-
Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem? Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-18 Sivaram Neppala, Jemema Rajan, Eric Yang, Ralph A. DeFronzo
-
Occupational Risks of Radiation Exposure to Cardiologists Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-16 Jean-Benoît Veillette, Marc-Antoine Carrier, Stéphane Rinfret, Julien Mercier, Jean Arsenault, Jean-Michel Paradis
-
Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time? Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-15 Simone Fezzi, Sara Malakouti, Jegan Sivalingam, Jacinthe Khater, Flavio Ribichini, Bernardo Cortese
-
Impact of Social Determinants of Health on Outcomes for Patients with Adult Congenital Heart Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-13 Suhas Babu, Paulamy Ganguly, Nandan Shettigar, C. Huie Lin
Purpose of Review The study of adults with congenital heart disease (ACHD) is a rapidly growing field; however, more research is needed on the disparities affecting outcomes. With advances in medicine, a high percentage of patients with congenital heart disease (CHD) are advancing to adulthood, leading to an increase in the number of ACHD. This creates a pressing need to evaluate the factors, specifically
-
Arrhythmogenesis in Fabry Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-12 Ashwin Roy, Max J. Cumberland, Christopher O’Shea, Andrew Holmes, Manish Kalla, Katja Gehmlich, Tarekegn Geberhiwot, Richard P. Steeds
-
Caring for the Critically Ill Adult Congenital Heart Disease Patient Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-09 Thomas Das, Penelope Rampersad, Joanna Ghobrial
Purpose of Review This review aims to discuss the unique challenges that adult congenital heart disease (ACHD) patients present in the intensive care unit. Recent Findings Recent studies suggest that ACHD patients make up an increasing number of ICU admissions, and that their care greatly improves in centers with specialized ACHD care. Common reasons for admission include arrhythmia, hemorrhage, heart
-
Contemporary Risk Models for In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-09 Christine Chow, Jacob Doll
-
Right Ventricle-Pulmonary Artery Coupling in Patients Undergoing Cardiac Interventions Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-06 Crosby Culp, Jon Andrews, Katherine Wang Sun, Kendall Hunter, Anne Cherry, Mihai Podgoreanu, Alina Nicoara
-
Insights into the Inherited Basis of Valvular Heart Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-06 Mengyao Yu, Nabila Bouatia-Naji
-
Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-04 Robert S. Zhang, Brittany N Weber, Diego Araiza-Garaygordobil, Michael S. Garshick
Purpose of Review Targeting traditional cardiovascular risk factors is effective in reducing recurrent cardiovascular events, yet the presence of residual cardiovascular risk due to underlying systemic inflammation is a largely unaddressed opportunity. This review aims to comprehensively assess the evolving role of colchicine as a therapeutic approach targeting residual inflammatory risk in the context
-
Intraoperative Echocardiography: Guide to Decision-Making Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-04 Michael Cutrone, Sarah Cotter, Madhav Swaminathan, Sharon McCartney
Purpose of Review This review aims to provide a concise overview of key recommendations, with a specific focus on common challenges faced by intraoperative echocardiographers when dealing with frequently encountered valvular pathologies and mechanical circulatory support. It offers valuable insights for medical practitioners in this field. Recent Findings The American Society of Echocardiography (ASE)
-
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-03
Abstract Purpose of Review Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age. It has been associated with metabolic, reproductive, and psychiatric disorders. Despite its association with insulin resistance (IR) and cardiovascular disease (CVD) risk factors, the association between PCOS and CVD outcomes has been conflicting. This review reports the updated
-
Polypill Strategy in Secondary Cardiovascular Prevention Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-04-01 Alan De la Rosa, Kedzie Arrington, Rohan Desai, Prakrati C. Acharya
Purpose of Review The polypill strategy, originally developed to improve medication adherence, has demonstrated efficacy in improving baseline systolic blood pressures and cholesterol levels in multiple clinical trials. However, the long-term clinical impact of improved major cardiovascular events (MACE) outcomes by the polypill remains uncertain. Recent Findings Recent trials with long-term follow-up
-
Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-29 Josephine Harrington, G. Michael Felker, James L. Januzzi, Carolyn S. P. Lam, Ildiko Lingvay, Neha J. Pagidipati, Naveed Sattar, Harriette G. C. Van Spall, Subodh Verma, Darren K. McGuire
Purpose of Review Obesity is associated with cardiovascular (CV) conditions, including but not limited to atherosclerotic disease, heart failure, and atrial fibrillation. Despite this, the impact of intentional weight loss on CV outcomes for persons with obesity and established CV conditions remains poorly studied. New and emerging pharmacologic therapies for weight loss primarily targeting the incretin/nutrient
-
Understanding the Genetic and Non-genetic Interconnections in the Aetiology of Isolated Congenital Heart Disease: An Updated Review: Part 1 Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-28 Jyoti Maddhesiya, Bhagyalaxmi Mohapatra
-
Planting the Seed for Blood Pressure Control: The Role of Plant-Based Nutrition in the Management of Hypertension Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-25 Justin A. Charles, Nilofer Khan Habibullah, Saul Bautista, Brenda Davis, Shivam Joshi, Sarah C. Hull
-
Echocardiography in the Recognition and Management of Mechanical Complications of Acute Myocardial Infarction Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-25 Robert S. Zhang, Richard Ro, Daniel Bamira, Alan Vainrib, Lily Zhang, Ambika C. Nayar, Muhamed Saric, Samuel Bernard
-
Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Aortic Regurgitation Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-22 Mujtaba Saeed, Akila Bersali, Amr Darwish, Fatima Qamar, Dimitrios Maragiannis, Kinan Carlos El-Tallawi, Maan Malahfji, Dipan J. Shah
-
What Do We Know So Far About Ventricular Arrhythmias and Sudden Cardiac Death Prediction in the Mitral Valve Prolapse Population? Could Biomarkers Help Us Predict Their Occurrence? Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-20 D. Dziadosz, L. Daniłowicz-Szymanowicz, P. Wejner-Mik, M. Budnik, B. Brzezińska, P. Duchnowski, K. Golińska-Grzybała, K. Jaworski, I. Jedliński, M. Kamela, J. Kasprzak, M. Kowalczyk-Domagała, K. Kurnicka, D. Kustrzycka-Kratochwil, K. Mickiewicz, O. Możeńska, Z. Oko-Sarnowska, M. Plewka, A. Polewczyk, B. Uziębło-Życzkowska, K. Wierzbowska-Drabik, R. Wachnicka-Truty, E. Wołoszyn-Horák, P. Szymański,
-
Systematic Review of Literature Citing the ISCHEMIA Trial Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-16
Abstract Purpose of Review Optimal therapy for patients with chronic coronary artery disease (CCD) has long been a topic under investigation and a subject of debate. Seeking to clarify appropriate management, the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial compared medical management versus coronary angiography for patients with stable
-
Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-16 Devinder S. Dhindsa, Wissam Mekary, Mikhael F. El-Chami
-
Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-14 Besher Sadat, Haider Al Taii, Muhie Sabayon, Chockalingam A. Narayanan
-
Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-12 Spencer Ng, Taylor Cunningham, John P. Vavalle
-
Diagnosis and Management of Congenital Coronary Artery Fistulas in Adults Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-11 Jaya Kanduri, Zachary Falk, Harsimran S. Singh
-
Acute Coronary Syndrome in Women: An Update Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-11 Madeleine R. Alder, Kylie E. Adamek, Angela Lowenstern, Leah M. Raj, Kathryn J. Lindley, Nadia R. Sutton
-
Cardiorespiratory and Muscular Fitness in Children and Adolescents with Obesity Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-09
Abstract Purpose of Review Examine the current state of literature related to the impact of obesity in children and adolescents on health-related physical fitness and the resultant cardiometabolic disease risk. Recent Findings Cardiorespiratory fitness of children and adolescents has declined over the past few decades which corresponds with an increase in obesity rates. Children with obesity are more
-
Management Considerations for Acute Coronary Syndromes in Chronic Kidney Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-07 Matthew I. Tomey, Janice Y. Chyou
-
Updates on Non-Statin LDL-Lowering Therapy Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-03-04 Amer Abdulla, Mostafa Shalaby, Paul Kumfa, Muhammad Raja, Joseph Allencherril, Tareq Abu Sharifeh
Purpose of Review There is ample evidence of the benefits and safety of low-density lipoprotein (LDL)-lowering therapies in the prevention of atherosclerotic cardiovascular disease. While statins remain the first-line agent for LDL reduction, several new therapies are now available. This narrative review provides an overview of currently available non-statin LDL-lowering agents, specifically mechanisms
-
Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-26 Silvia Moscardelli, Reza Masoomi, Pedro Villablanca, Ahmad Jabri, Ankitkumar K. Patel, Francesco Moroni, Lorenzo Azzalini
-
The Global Epidemic of Metabolic Fatty Liver Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-20
Abstract Purpose of Review The objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD), its correlation with cardiovascular disease (CVD) outcomes, as well as to evaluate the update in nomenclature from non-alcoholic liver disease (NAFLD). Recent Findings The update of diagnostic criteria from NAFLD to
-
Echogenomics: Echocardiography in Heritable Aortopathies Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-19 Lyndsey Hunter-Adamson, Seda Tierney
-
Understanding the Genetic and Non-Genetic Interconnections in the Aetiology of Syndromic Congenital Heart Disease: An Updated Review: Part 2 Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-15 Jyoti Maddhesiya, Bhagyalaxmi Mohapatra
Purpose of Review Approximately 30% of syndromic cases diagnosed with CHD, which lure us to further investigate the molecular and clinical challenges behind syndromic CHD (sCHD). The aetiology of sCHD in a majority of cases remains enigmatic due to involvement of multiple factors, namely genetic, epigenetic and environmental modifiable risk factors for the development of the disease. Here, we aim to
-
Open Surgical Therapy for Peripheral Artery Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-12 Emmanuel C. Nwachuku, Alik Farber
-
Update on the Role of Colchicine in Cardiovascular Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-10 Darcy Banco, Mohammad Mustehsan, Binita Shah
Purpose of Review This review focuses on the use of colchicine to target inflammation to prevent cardiovascular events among those at-risk for or with established coronary artery disease. Recent Findings Colchicine is an anti-inflammatory drug that reduces cardiovascular events through its effect on the IL-1β/IL-6/CRP pathway, which promotes the progression and rupture of atherosclerotic plaques. Clinical
-
Lysophosphatidic Acid-Mediated Inflammation at the Heart of Heart Failure Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-10 Rajesh Chaudhary, Tahra Suhan, Mahmud W. Tarhuni, Ahmed Abdel-Latif
-
Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-02-07 Enrico Ammirati, Nicolina Conti, Matteo Palazzini, Matteo Rocchetti, Andrea Spangaro, Andrea Garascia, Laura Lupi, Alberto Cereda
-
Combined Heart Kidney Transplantation Versus Heart Transplant in Patients with Renal Failure: Contemporary Insights and Future Perspectives Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-31 Anju Bhardwaj, Preethi Pirlamarla, Yevgeniy Brailovsky, Ajith Nair, Indranee Rajapreyar
-
The Expansion of Genetic Testing in Cardiovascular Medicine: Preparing the Cardiology Community for the Changing Landscape Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-26 Nosheen Reza, Raye L. Alford, John W. Belmont, Nicholas Marston
-
Nutritional Aspects to Cardiovascular Diseases and Type 2 Diabetes Mellitus Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-23 Hayley E. Billingsley, Emily M. Heiston, Moriah P. Bellissimo, Carl J. Lavie, Salvatore Carbone
-
Spontaneous Coronary Artery Dissection (SCAD) from an Interventionalist Perspective Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-18
Abstract Purpose of Review Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS), particularly among women < 50 years of age. Here, we aim to review the pathogenesis of SCAD, discuss SCAD as an initial manifestation of systemic arterial disease, and highlight invasive strategies as well as unique challenges in the care of women with SCAD
-
Post Cardiac Arrest Care in the Cardiac Intensive Care Unit Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-12
Abstract Purpose of Review Cardiac arrests constitute a leading cause of mortality in the adult population and cardiologists are often tasked with the management of patients following cardiac arrest either as a consultant or primary provider in the cardiac intensive care unit. Familiarity with evidence-based practice for post-cardiac arrest care is a requisite for optimizing outcomes in this highly
-
MicroRNAs and Cardiovascular Disease Risk Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2024-01-11 Charles D. Searles
Purpose of Review MicroRNAs (miRNAs)—short, non-coding RNAs—play important roles in almost all aspects of cardiovascular biology, and changes in intracellular miRNA expression are indicative of cardiovascular disease development and progression. Extracellular miRNAs, which are easily measured in blood and can be reflective of changes in intracellular miRNA levels, have emerged as potential non-invasive
-
Patient Engagement in Research: Considerations in Creating a Registry for Adults with Congenital Heart Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-22 Ruth Phillippi, Scott Leezer, Mindi Messmer, Danielle Hile, Anitha S. John
-
Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-20 Mia M. Pries-Heje, Henning Bundgaard, Kasper K. Iversen, Lindsey R. Baden, Ann E. Woolley
Purpose of Review The question of antibiotic prophylaxis and its role in prevention of infective endocarditis (IE) remains controversial, with differing recommendations from international societies. The aim of this review was to compare and contrast current recommendations on antibiotic prophylaxis for IE by the American Heart Association (AHA), the European Society of Cardiology (ESC), and the National
-
Exercise as Medicine: Evaluation and Prescription for Adults with Congenital Heart Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-20 David Leone, Jonathan Buber, Keri Shafer
-
Medical and Mechanical Circulatory Support of the Failing Right Ventricle Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-18 Eugene Yuriditsky, Meshe Chonde, Oren Friedman, James M. Horowitz
-
Assessment of the Severity of Aortic Regurgitation by Noninvasive Imaging Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-13 Elena Ferrer-Sistach, Albert Teis, Claudia Escabia, Victoria Delgado
-
Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-11 Matthew E. Gold, Edward Woods, Darlington Pobee, Rand Ibrahim, Arshed A. Quyyumi
-
Cardiac Rehabilitation After Hospitalization for Acute Coronary Syndrome Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-08 Ravi Thakker, Mahin Khan, Bashar Al-Hemyari
-
Multimodality Imaging Approach Evaluation of the Congenital Pericardial Defect: a Contemporary Review Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-07 Mohamed Khayata, Alice A. Haouzi, Craig R. Asher, Bo Xu
-
Diagnosis and Management of Congenital Coronary Artery Fistulas in Infants and Children Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-05 Stephan Wu, Munes Fares, Thomas M. Zellers, Maanya Jyothinagaram, Surendranath R. Veeram Reddy
-
The Echocardiographic Evaluation of the Right Heart: Current and Future Advances Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-12-02 Christian O’Donnell, Pablo Amador Sanchez, Bettia Celestin, Michael V. McConnell, Francois Haddad
-
The Brain–Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-11-23 Jiun-Ruey Hu, Ahmed Abdullah, Michael G. Nanna, Robert Soufer
-
Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-11-22 Jinwook Park, Chien-Wen Yang, Yonghong Huan, Sandeep Aggarwal
Purpose of Review The number of medications prescribed to patients has been progressively increasing, primarily driven by cardioprotective medications. The advent of pharmaceutical 3D printing technology holds the promise of reducing the burden of multiple pills by combining various medications with different release mechanisms into a single tablet. This development encourages a comprehensive review
-
Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with Diabetes Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-11-22 Ulrich Kintscher
Purpose of Review Novel non-steroidal mineralocorticoid receptor (MR) antagonists (MRAs) are a new class of drugs blocking adverse MR-mediated effects with an improved benefit-risk profile compared to steroidal MRAs. This review will provide information on the preclinical and clinical pharmacology of this new drug class and will discuss their future clinical applications in patients with cardiorenal
-
Global Cardiovascular Research: Gaps and Opportunities Curr. Cardiol. Rep. (IF 3.7) Pub Date : 2023-11-20 Maha Inam, Zainab Samad, Elizabeth M. Vaughan, Aysha Almas, Bashir Hanif, Abdul Mannan Minhas, Zeerak Jarrar, Fatima Zohra Habib, Sana Sheikh, Dongshan Zhu, Salim S. Virani